You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma in Brain and CNS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,

Active, not recruiting
  • CNS Lymphoma
  • +2 more
  • Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
  • Basking Ridge, New Jersey
  • +2 more
Jan 27, 2023

Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)

Recruiting
  • Primary Central Nervous System Lymphoma
  • +2 more
  • Guandong, Guangdong, China
  • +2 more
Apr 6, 2022

Malignant Tumors, Brain Lymphoma, CNS Lymphoma Trial in Seoul (Usefulness of Gadovist-enhanced FLAIR imaging in differentiation

Completed
  • Malignant Tumors
  • +2 more
  • Usefulness of Gadovist-enhanced FLAIR imaging in differentiation between a glioblastoma and solitary brain metastasis
  • Seoul, Gurogu, Korea, Republic of
    Korea University Guro Hospital
Mar 14, 2022

Refractory and Relapsed Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guangzhou (Orelabrutinib, Thiotepa)

Not yet recruiting
  • Refractory and Relapsed Primary CNS Lymphoma
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Aug 19, 2021

Prospective Neurobehavioral Functions in Newly-diagnosed Primary

Recruiting
  • Primary CNS Lymphoma
  • Brain Lymphoma
  • A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Mar 9, 2021

CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)

Recruiting
  • CNS Lymphoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 10, 2022

Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

Not yet recruiting
  • Non-hodgkin Lymphoma, B Cell
  • ctDNA detection
  • Aarau, Switzerland
  • +12 more
Oct 18, 2023

CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study

Not yet recruiting
  • CNS Lymphoma
    • London, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Apr 12, 2023

    CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

    Active, not recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • DISEASE
    • (no location specified)
    May 4, 2023

    Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

    Recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
      • Milan, Italy
        Ospedale San Raffaele
      Aug 29, 2023

      Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

      Recruiting
      • Lymphoma
      • Lymphoma Cns
      • Boston, Massachusetts
      • +1 more
      Jan 3, 2023

      CNS Lymphoma Trial in Essen ([90Y]Y-PentixaTher)

      Recruiting
      • CNS Lymphoma
      • Essen, Germany
        University Hospital Essen
      Nov 16, 2023

      Primary CNS Lymphoma Trial in Paris (PET-MRI)

      Not yet recruiting
      • Primary Central Nervous System Lymphoma
      • Paris, France
        Hôpital Pitié Salpêtrière
      May 20, 2022

      CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

      Recruiting
      • Central Nervous System Lymphoma
      • Secondary Central Nervous System Lymphoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

      Completed
      Has Results
      • Brain Stem Neoplasm
      • +9 more
      • Birmingham, Alabama
      • +20 more
      Jan 6, 2023

      CNS Lymphoma Trial (68Ga-PTF)

      Recruiting
      • CNS Lymphoma
      • Aalborg, Denmark
      • +1 more
      Jan 17, 2023

      Cerebral Stroke, Traumatic Brain Injury, Spinal Cord Injuries Trial in Los Angeles (HandyMotion Treatment Program)

      Not yet recruiting
      • Cerebral Stroke
      • +2 more
      • HandyMotion Treatment Program
      • Los Angeles, California
        California Rehabilitation Institute
      Oct 9, 2023

      Primary CNS Lymphoma Trial in San Francisco (Hyperpolarized pyruvate (13C), Magnetic resonance imaging (MRI))

      Recruiting
      • Primary CNS Lymphoma
      • Hyperpolarized pyruvate (13C)
      • Magnetic resonance imaging (MRI)
      • San Francisco, California
        University of California, San Francisco
      Apr 22, 2022

      Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

      Not yet recruiting
      • Non-hodgkin Lymphoma
      • (no location specified)
      Aug 11, 2023

      Brain Cancer, Cognitive Impairment Trial (ImPACT program)

      Not yet recruiting
      • Brain Cancer
      • Cognitive Impairment
      • ImPACT program
      • (no location specified)
      May 11, 2023

      Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FTD regimen)

      Completed
      • Primary CNS Lymphoma (PCNSL)
      • HD-MTX-Ara-C regimen
      • FTD regimen
      • Zhengzhou, Henan, China
        Oncology Department of The First Affiliated Hospital of Zhengzho
      Mar 2, 2022

      Primary CNS Lymphoma Trial in London (CD19CAR T-cells)

      Recruiting
      • Primary CNS Lymphoma
      • CD19CAR T-cells
      • London, United Kingdom
        University College London Hospital
      Jun 13, 2022

      Primary CNS Lymphoma Trial in Stuttgart (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix,

      Recruiting
      • Primary Central Nervous System Lymphoma
      • Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix
      • Control intervention: four courses of MATRix
      • Stuttgart, Baden-Württemberg, Germany
        Klinikum Stuttgart
      Feb 15, 2022

      Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

      Available
      • Glioblastoma
      • +13 more
      • (no location specified)
      Jul 26, 2023